SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Feb-24 4:42 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 02-Feb-24 | Payment of Exercise | 1,288 | $1.51 | $1,944.88 | (< 1%) 842.23K to 840.94K | |
04-Jan-24 4:43 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 02-Jan-24 | Grant | 590,413 | -- | -- | 234% 251.81K to 842.23K | |
25-Aug-23 4:30 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 24-Aug-23 | Sale (Planned) | 33,000 | $2.33 | $76,890.00 | (11%) 291.04K to 258.04K | |
02-Jun-23 4:12 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 31-May-23 | Grant | 6,230 | -- | -- | 2% 284.81K to 291.04K | |
06-Feb-23 9:12 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 02-Feb-23 | Grant | 18,691 | -- | -- | 7% 266.12K to 284.81K | |
24-Aug-22 4:47 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 23-Aug-22 | Sale (Planned) | 3,325 | $3.47 | $11,537.80 | (1%) 269.45K to 266.12K | |
22-Aug-22 8:05 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 22-Aug-22 | Sale (Planned) | 9,717 | $3.50 | $34,009.50 | (3%) 279.16K to 269.45K | |
22-Aug-22 8:05 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 19-Aug-22 | Sale (Planned) | 11,482 | $3.75 | $43,057.50 | (4%) 290.64K to 279.16K | |
22-Aug-22 8:05 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 18-Aug-22 | Sale (Planned) | 7,476 | $3.87 | $28,932.10 | (3%) 298.12K to 290.64K | |
20-Aug-21 5:52 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 20-Aug-21 | Market Sale (Planned) | 11,840 | $16.78 | $198,649.00 | (4%) 309.96K to 298.12K | 3% |
20-Aug-21 5:52 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 19-Aug-21 | Market Sale (Planned) | 9,967 | $16.47 | $164,175.00 | (3%) 319.93K to 309.96K | 1% |
20-Aug-21 5:52 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 18-Aug-21 | Market Sale (Planned) | 11,193 | $17.35 | $194,199.00 | (3%) 331.12K to 319.93K | 6% |
25-Sep-20 5:08 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 23-Sep-20 | Grant | 331,121 | -- | -- | 100% 0 to 331.12K |